Bulk en botox tegen urineverlies

•Download as PPTX, PDF•

0 likes•805 views

This document discusses BOTOX and bulking agents for treating urinary incontinence. It covers how BOTOX works, what material is used for bulking injections, whether injections are done under sight or with a device, and guidelines for using BOTOX and bulking agents for both men and women. Videos are also linked that further explain bulking injections using Bulkamid.

Health & Medicine

BULKINJECTIES: ONDER ZICHT OF MET DEVICE?

BULKINJECTIES: BULKAMID
https://www.youtube.com/watch?v=jNYRoFeHxXA
https://www.youtube.com/watch?v=3TyIDoFrfSk

GENOMINEERD! Wint ons artikel over één week de Rijnstate ‘artikel van het jaar’-prijs?!? Het artikel ‘How do patients understand questions about lower urinary tract symptoms? A qualitive study of problems in completing urological questionnaires’ is een van de drie genomineerden. Met Florine Schlatmann, Igle J. de Jong MD, PhD , Andrea de Winter en Carel Jansen werd onderzocht hoe een ontzettend veel gebruikte scorelijst voor mannen met plasklachten (de IPSS), te begrijpen is voor wie prima kan lezen en schrijven, maar ook voor wie daar moeite mee heeft (#laaggeletterdheid). En dat viel tegen! Ook twee varianten, met veel meer illustraties werden onderzocht: die werden beter begrepen, ook al waren daar ook wel wat opmerkingen. Omdat het over zoveel mensen gaat (heel veel mensen hebben moeite met lezen en schrijven en heel veel mannen krijgen plasklachten) hopen we een goede kans te maken op een goede uitkomst! 30 mei, duimt (of stemt!) u mee?

Zorg en Taal V&VN cv&v 2023.pptx

Michael van Balken

Zorg en Taal Elkerliek 2023

Michael van Balken

Zorg en taal 2023 Losgio

Michael van Balken

PTNS Percutaneous Tibial Nerve Stimulation

Michael van Balken

The document discusses percutaneous tibial nerve stimulation (PTNS), a treatment for overactive bladder syndrome. It describes PTNS treatment parameters including frequency, pulse width and voltage. PTNS involves 12 weekly sessions, with the frequency of sessions decreasing over time. The document also summarizes a randomized controlled trial that compared the efficacy of PTNS versus sham therapy in treating overactive bladder symptoms. The trial found that PTNS significantly improved patient global response assessments, voiding diary parameters and quality of life questionnaires compared to sham therapy.

Workshop D3 FU 2023.pptx

Michael van Balken

Urodynamica FU 2023.pptx

Michael van Balken

This document discusses parameters that are measured during urodynamics testing in females. It lists items that are recorded for micturition lists including frequency, volumes, duration, and incontinence episodes. It also outlines measurements that are made for free flow, filling phase, voiding phase, bladder pressure-volume relationship, urethral pressure profile, and indices like bladder outlet obstruction index and bladder contractility index. The purpose of urodynamics testing is to objectively evaluate lower urinary tract function and diagnose incontinence or other issues.

Zorg en Taal PRO meeting 2022 .pptx

Michael van Balken

Urodynamica

Michael van Balken

This document discusses urodynamics, which is a urology symposium presentation on September 30th, 2022. It outlines the various measurements and assessments that are part of a urodynamics test, including voiding diaries, free flow measurements, filling phase measurements, voiding phase measurements, and urethral pressure profile measurements. The purpose is to evaluate bladder storage and voiding functions through cystometry and uroflowmetry to diagnose incontinence and other lower urinary tract dysfunctions.

Towards a future of sustainable continence care: 'green' care and therapy ini...

Michael van Balken

This document discusses initiatives to make continence care more sustainable, including rethinking catheter and material use to reduce waste, innovating new therapies, addressing misconceptions among patients and others about incontinence, and improving health literacy through decision aids and easier to understand information. It also calls for scientific organizations and patient groups to join efforts towards a more sustainable future of continence care.

Finding ways to optimally inform patients with lacking digital or literacy sk...

Michael van Balken

Taalvaardigheid in de zorg

Michael van Balken

Besnijdenis bij jongens

Michael van Balken

Zorg en Taal COBRADAGEN 2022.pptx

Michael van Balken

Zorg en Taal V&VN VSO 2022.pptx

Michael van Balken

Efficacy of Avartana Sneha in Ayurveda

Dr. Jyothirmai Paindla

CHEMOTHERAPY_RDP_CHAPTER 2 _LEPROSY.pdf1

rishi2789

Recently uploaded

Efficacy of Avartana Sneha in Ayurveda

Dr. Jyothirmai Paindla

CHEMOTHERAPY_RDP_CHAPTER 2 _LEPROSY.pdf1

rishi2789

Journal Article Review on Rasamanikya

Dr. Jyothirmai Paindla

Rasamanikya is a excellent preparation in the field of Rasashastra, it is used in various Kushtha Roga, Shwasa, Vicharchika, Bhagandara, Vatarakta, and Phiranga Roga. In this article Preparation& Comparative analytical profile for both Formulationon i.e Rasamanikya prepared by Kushmanda swarasa & Churnodhaka Shodita Haratala. The study aims to provide insights into the comparative efficacy and analytical aspects of these formulations for enhanced therapeutic outcomes.

share - Lions, tigers, AI and health misinformation, oh my!.pptx

Tina Purnat

• Pitfalls and pivots needed to use AI effectively in public health • Evidence-based strategies to address health misinformation effectively • Building trust with communities online and offline • Equipping health professionals to address questions, concerns and health misinformation • Assessing risk and mitigating harm from adverse health narratives in communities, health workforce and health system

CBL Seminar 2024_Preliminary Program.pdf

suvadeepdas911

Ketone bodies and metabolism-biochemistry

Dhayanithi C

Aortic Association CBL Pilot April 19 – 20 Bern

suvadeepdas911

Vestibulocochlear Nerve by Dr. Rabia Inam Gandapore.pptx

Dr. Rabia Inam Gandapore

CHEMOTHERAPY_RDP_CHAPTER 3_ANTIFUNGAL AGENT.pdf

rishi2789

Physical demands in sports - WCSPT Oslo 2024

Torstein Dalen-Lorentsen

Role of Mukta Pishti in the Management of Hyperthyroidism

Dr. Jyothirmai Paindla

Cardiac Assessment for B.sc Nursing Student.pdf

shivalingatalekar1

Muscles of Mastication by Dr. Rabia Inam Gandapore.pptx

Dr. Rabia Inam Gandapore

Adhd Medication Shortage Uk - trinexpharmacy.com

reignlana06

The UK is currently facing a Adhd Medication Shortage Uk, which has left many patients and their families grappling with uncertainty and frustration. ADHD, or Attention Deficit Hyperactivity Disorder, is a chronic condition that requires consistent medication to manage effectively. This shortage has highlighted the critical role these medications play in the daily lives of those affected by ADHD. Contact : +1 (747) 209 – 3649 E-mail : sales@trinexpharmacy.com

Complementary feeding in infant IAP PROTOCOLS

chiranthgowda16

All info about Diabetes and how to control it.

Gokuldas Hospital

Clinic ^%[+27633867063*Abortion Pills For Sale In Tembisa Central

19various

Cell Therapy Expansion and Challenges in Autoimmune Disease

Health Advances

There is increasing confidence that cell therapies will soon play a role in the treatment of autoimmune disorders, but the extent of this impact remains to be seen. Early readouts on autologous CAR-Ts in lupus are encouraging, but manufacturing and cost limitations are likely to restrict access to highly refractory patients. Allogeneic CAR-Ts have the potential to broaden access to earlier lines of treatment due to their inherent cost benefits, however they will need to demonstrate comparable or improved efficacy to established modalities. In addition to infrastructure and capacity constraints, CAR-Ts face a very different risk-benefit dynamic in autoimmune compared to oncology, highlighting the need for tolerable therapies with low adverse event risk. CAR-NK and Treg-based therapies are also being developed in certain autoimmune disorders and may demonstrate favorable safety profiles. Several novel non-cell therapies such as bispecific antibodies, nanobodies, and RNAi drugs, may also offer future alternative competitive solutions with variable value propositions. Widespread adoption of cell therapies will not only require strong efficacy and safety data, but also adapted pricing and access strategies. At oncology-based price points, CAR-Ts are unlikely to achieve broad market access in autoimmune disorders, with eligible patient populations that are potentially orders of magnitude greater than the number of currently addressable cancer patients. Developers have made strides towards reducing cell therapy COGS while improving manufacturing efficiency, but payors will inevitably restrict access until more sustainable pricing is achieved. Despite these headwinds, industry leaders and investors remain confident that cell therapies are poised to address significant unmet need in patients suffering from autoimmune disorders. However, the extent of this impact on the treatment landscape remains to be seen, as the industry rapidly approaches an inflection point.

NARCOTICS- POLICY AND PROCEDURES FOR ITS USE

Dr. Ahana Haroon

Outbreak management including quarantine, isolation, contact.pptx

Pratik328635